Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin for Smoking Cessation Mechanisms
NCT04396834Phase 2Terminated
- Sponsor
- The Mind Research Network
- Start
- Dec 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lorcaserin in Tobacco Use Disorder (TUD), sponsored by The Mind Research Network. Started Dec 2019; status: terminated.
02
Drugs
lorcaserin
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04396834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04396834.